Back to Agenda
Session 10 Track 4: Electronic Product Information (ePI): A Digital Passport for Therapeutic Product Information
Session Chair(s)
Jo English
, IRISS Forum, United Kingdom
This session will provide a holistic view of electronic Product Information (ePI), emphasizing its significance in delivering timely drug information to patients and healthcare providers. You’ll gain insights into the current status of ePI adoption and discover the essential factors needed for its global implementation.
Learning Objective : At the conclusion of this session, participants should be able to:- Understand the purpose of ePI & how it fits within regulatory ecosystem
- Highlight the current state of ePI adoption globally
- Describe the benefits of adopting ePI, best practices for implementation, and barriers to adoption
- Explain how ePI interacts with global data standard initiatives & Why it matters
Speaker(s)
Electronic Product Information (ePI): A Digital Passport for Therapeutic Product Information; case study : "Unlocking ePI: A Possible Solution to Drug Shortage Management"
Katja Pecjak, MPharm
Director BD, Sales and Marketing, Billev Pharma East Ltd., Slovenia
Electronic Product Information (ePI): A Digital Passport for Therapeutic Product Information
Scott Gordon, PhD
Associate Director, Data Acquisitions - eSource, Johnson & Johnson Innovative Medicine, United States
Speaker
Cesar Vinces
Advisor, Regulatory Innovation, Nuvara, United States
Speaker
Hilmar Hamann, PhD
Chief Information Officer, European Medicines Agency, Netherlands
Speaker
Niklas Jaenich, PhD, RPh
Head of Global Labeling Operations and Digitization, Boehringer Ingelheim, Germany
Have an account?